ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 151 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $21,280 | -10.7% | 21,714 | +26.7% | 0.00% | – |
| Q2 2023 | $23,819 | +4.5% | 17,136 | +19.5% | 0.00% | – |
| Q1 2023 | $22,797 | -90.4% | 14,338 | -62.2% | 0.00% | – |
| Q4 2022 | $236,291 | +242.5% | 37,928 | +249.9% | 0.00% | – |
| Q2 2022 | $69,000 | -89.2% | 10,840 | -52.3% | 0.00% | -100.0% |
| Q1 2021 | $637,000 | +111.6% | 22,721 | +96.5% | 0.00% | – |
| Q4 2020 | $301,000 | -9.1% | 11,560 | +30.0% | 0.00% | – |
| Q3 2020 | $331,000 | +29.8% | 8,893 | +79.1% | 0.00% | – |
| Q2 2020 | $255,000 | +7.6% | 4,965 | +24.9% | 0.00% | – |
| Q4 2019 | $237,000 | +0.9% | 3,975 | -21.4% | 0.00% | – |
| Q2 2019 | $235,000 | -20.9% | 5,060 | -24.5% | 0.00% | – |
| Q3 2018 | $297,000 | +23.2% | 6,699 | +28.8% | 0.00% | -100.0% |
| Q2 2017 | $241,000 | – | 5,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 3,791,300 | $3,715,474 | 4.82% |
| Two Seas Capital LP | 7,672,170 | $7,518,727 | 1.51% |
| Parkman Healthcare Partners LLC | 1,997,071 | $1,957,130 | 0.36% |
| Monaco Asset Management SAM | 1,171,779 | $1,148,343 | 0.34% |
| TANG CAPITAL MANAGEMENT LLC | 1,850,000 | $1,813,000 | 0.26% |
| Ikarian Capital, LLC | 1,737,636 | $1,702,883 | 0.20% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 3,189,517 | $3,125,727 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 1,116,655 | $1,094 | 0.09% |
| XTX Topco Ltd | 519,129 | $508,746 | 0.09% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 60,000 | $58,800 | 0.08% |